Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

RxSight (RXST) Operating Expenses (2020 - 2026)

RxSight filings provide 6 years of Operating Expenses readings, the most recent being $36.6 million for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 2.18% to $36.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $151.2 million, a 11.34% increase, with the full-year FY2025 number at $151.2 million, up 11.34% from a year prior.
  • Operating Expenses hit $36.6 million in Q4 2025 for RxSight, up from $36.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $39.2 million in Q2 2025 to a low of $12.3 million in Q1 2021.
  • Median Operating Expenses over the past 5 years was $25.9 million (2023), compared with a mean of $26.6 million.
  • Biggest five-year swings in Operating Expenses: soared 81.08% in 2021 and later decreased 2.18% in 2025.
  • RxSight's Operating Expenses stood at $17.5 million in 2021, then rose by 27.83% to $22.4 million in 2022, then rose by 27.19% to $28.5 million in 2023, then surged by 31.26% to $37.4 million in 2024, then fell by 2.18% to $36.6 million in 2025.
  • The last three reported values for Operating Expenses were $36.6 million (Q4 2025), $36.4 million (Q3 2025), and $39.2 million (Q2 2025) per Business Quant data.